Repligen Corp. (RGEN)
108.50
+4.30
(+4.13%)
USD |
NASDAQ |
May 19, 16:00
109.32
+0.82
(+0.76%)
After-Hours: 20:00
Repligen Research and Development Expense (Quarterly) : 14.46M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | 15.80M |
| Reflect Scientific, Inc. | 0.0057M |
| Quantum-Si, Inc. | 14.49M |
| BioLife Solutions, Inc. | 2.65M |
| Baxter International, Inc. | 124.00M |